FOR RELEASE 10/14/2010, Thursday
MADISON, N.J. — Bausch + Lomb, the global eye health company, has released a redesign of its PreserVision® Eye Vitamin AREDS 2 Formula.
The new, smaller soft gel is dosed twice per day, two pills per dose. Bausch + Lomb chose to redesign the pills based on customer feedback, making the product smaller in size. The product was voluntarily recalled in July 2010 due to concerns over the pill’s original size.
PreserVision Eye Vitamin AREDS 2 Formula builds on the original PreserVision Eye Vitamin Age-Related Eye Disease Study (AREDS) Formula by adding omega-3 fatty acids (1000 mg) per daily dosage, lutein (10 mg) and zeaxanthin (2 mg), replacing beta-carotene.
Scientific studies show that the inclusion of high levels of omega-3 fatty acids, lutein and zeaxanthin in the diet supports eye health*. Age-related macular degeneration (AMD) is the number one cause of severe vision loss in the United States for people over the age of 65.
According to Michael J. Cooney, MD, MBA, retina specialist at the Vitreous Retina Macula Consultants in New York, “There is growing interest in the use of these new ocular nutrients in clinical practice. PreserVision Eye Vitamin AREDS 2 Formula essentially mirrors what I am increasingly using in my clinical practice as more and more lutein and zeaxanthin (replacing beta-carotene) and omega-3 scientific data emerge. PreserVision Eye Vitamin AREDS 2 Formula offers patients the opportunity and convenience of getting these important ocular nutrients in a single product formulation.”
“Customer satisfaction is Bausch + Lomb’s top priority. As the market leader in ocular nutritionals for AMD, we felt it was critical that we bring this new formulation to the market in a convenient, smaller design,” said Philip Gioia, head of North America Pharmaceuticals.
# # #
About Bausch + Lomb
Bausch + Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch + Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.
AREDS2 is a registered trademark of The U.S. Department of Health and Human Services (HHS).
AREDS2® is an ongoing study that is expected to end in 2013.
®/™ denote trademarks of Bausch & Lomb Incorporated
* This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
The website you are about to visit is not affiliated with Bausch + Lomb Incorporated. Bausch + Lomb is not responsible for the content, format, maintenance, or policies of the website you are about to enter and does not monitor non-affiliated websites for accuracy. Links to non-affiliated websites are provided as a convenience; they do not constitute an endorsement or support of any programs, products, or services associated with the website.